Literature DB >> 26868522

Autosomal dominant polycystic kidney disease.

Roslyn J Simms1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26868522     DOI: 10.1136/bmj.i679

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Diagnostic approach and management of genetic aortopathies.

Authors:  Rohan Bhandari; Rajani D Aatre; Yogendra Kanthi
Journal:  Vasc Med       Date:  2020-02       Impact factor: 3.239

2.  The mutation-free embryo for in vitro fertilization selected by MALBAC-PGD resulted in a healthy live birth from a family carrying PKD 1 mutation.

Authors:  Wen Li; Yiyi Ma; Shengqiang Yu; Ningxia Sun; Liang Wang; Dongping Chen; Guijiang Yang; Sijia Lu; Yangyang Li; Bo Yang; Changlin Mei
Journal:  J Assist Reprod Genet       Date:  2017-08-19       Impact factor: 3.412

3.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

4.  Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.

Authors:  Hanlu Wang; Sen Dai; Jianhui Zhang; Yi Li; Yumian Gan; Tao Lu; Yaobin Zhu; Jiabin Wu; Ning Lin; Faqiang Tang; Jiewei Luo
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 5.  Polycystin and calcium signaling in cell death and survival.

Authors:  Fernanda O Lemos; Barbara E Ehrlich
Journal:  Cell Calcium       Date:  2017-05-24       Impact factor: 6.817

6.  Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation.

Authors:  Laurel Truscott; Joanna Gell; Vivian Y Chang; Hane Lee; Samuel P Strom; Rex Pillai; Anthony Sisk; Julian A Martinez-Agosto; Martin Anderson; Noah Federman
Journal:  Pediatr Blood Cancer       Date:  2016-08-31       Impact factor: 3.167

Review 7.  Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

8.  Increased risk of pulmonary and extrapulmonary tuberculosis infection in patients with polycystic kidney disease: a nationwide population-based study with propensity score-matching analysis.

Authors:  Tung-Min Yu; Chia-Hung Kao; Ting-Fang Chiu; Chih-Wei Chiu; Brian K Lee; Tsuo-Hung Lan; Chi-Yuan Li; Mei-Chen Lin
Journal:  J Transl Med       Date:  2021-06-09       Impact factor: 5.531

9.  Bilateral Nephrectomy for Adult Polycystic Kidney Disease Does Not Affect the Graft Function of Transplant Patients and Does Not Result in Sensitisation.

Authors:  Maria Irene Bellini; Sotiris Charalmpidis; Paul Brookes; Peter Hill; Frank J M F Dor; Vassilios Papalois
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

10.  The fertility willingness and acceptability of preimplantation genetic testing in Chinese patients with autosomal dominant polycystic kidney disease.

Authors:  Mingji Sun; Cheng Xue; Yunhui Lu; Yiyi Ma; Ting Pan; Xiaoliu Wang; Li Fan; Jiandong Shen; Yan Hao; Danxia Zheng; Junhua Li; Mingxu Li; Yaping He; Changlin Mei
Journal:  BMC Nephrol       Date:  2020-04-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.